about
Proteomic Investigations into Hemodialysis TherapyMagnetic separation-based blood purification: a promising new approach for the removal of disease-causing compounds?Immune dysfunction in uremia—an updateRhubarb Enema Attenuates Renal Tubulointerstitial Fibrosis in 5/6 Nephrectomized Rats by Alleviating Indoxyl Sulfate OverloadRegulatory pathways for ATP-binding cassette transport proteins in kidney proximal tubules[Clinical issues with uremia].Differential scaling of glomerular filtration rate and ingested metabolic burden: implications for gender differences in chronic kidney disease outcomesThe production of p-cresol sulfate and indoxyl sulfate in vegetarians versus omnivores.The uremic toxicity of indoxyl sulfate and p-cresyl sulfate: a systematic review.Relationship between magnesium and clinical biomarkers on inhibition of vascular calcification.Estimated glomerular filtration rate is a poor predictor of the concentration of middle molecular weight uremic solutes in chronic kidney diseaseRetained organic solutes, patient characteristics and all-cause and cardiovascular mortality in hemodialysis: results from the retained organic solutes and clinical outcomes (ROSCO) investigatorsAlteration of human blood cell transcriptome in uremia.Does p-cresylglucuronide have the same impact on mortality as other protein-bound uremic toxins?Indoxyl sulfate down-regulates SLCO4C1 transporter through up-regulation of GATA3.Estimated glomerular filtration rate is a poor predictor of concentration for a broad range of uremic toxinsDoes the adequacy parameter Kt/V(urea) reflect uremic toxin concentrations in hemodialysis patients?The use of SDS-PAGE scanning of spent dialysate to assess uraemic toxin removal by dialysis.Protein-bound solute removal during extended multipass versus standard hemodialysis.Alteration of the Intestinal Environment by Lubiprostone Is Associated with Amelioration of Adenine-Induced CKD.Effects of uremic solutes on reactive oxygen species in vitro model systems as a possibility of support the renal function managementCross-sectional examination of metabolites and metabolic phenotypes in uremia.Protein-Bound Uremic Toxin Profiling as a Tool to Optimize Hemodialysis.Removal of Different Classes of Uremic Toxins in APD vs CAPD: A Randomized Cross-Over StudyPrognosis of CKD patients receiving outpatient nephrology care in Italy.Haemocompatibility and ion exchange capability of nanocellulose polypyrrole membranes intended for blood purification.Reduced Microvascular Density in Omental Biopsies of Children with Chronic Kidney DiseaseThe Aryl Hydrocarbon Receptor is a Critical Regulator of Tissue Factor Stability and an Antithrombotic Target in Uremia.Serum Indoxyl Sulfate Associates with Postangioplasty Thrombosis of Dialysis Grafts.Bisphenol a in chronic kidney disease.A zebrafish model for uremic toxicity: role of the complement pathway.Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients.Neurological disorders in a murine model of chronic renal failurep-Cresyl Sulfate.Hemodiafiltration: the addition of convective flow to hemodialysis.Do clinical outcomes in chronic hemodialysis depend on the choice of a dialyzer?Uremic toxins and oral adsorbents.Cardiorenal syndrome: pathophysiology, preclinical models, management and potential role of uraemic toxins.Protein-bound uremic toxins: new insight from clinical studiesRole of dialysis technology in the removal of uremic toxins.
P2860
Q26774276-9A9500FD-EF3A-4586-B37C-CDB74FEF165DQ26801042-7A7F487A-6B57-479C-914E-7CF2B096D764Q26829076-35463D4E-0918-4017-99CC-91B0557B3BFDQ27335335-0516C498-4D59-443D-A0B9-2D7B45B3EEC0Q28390004-C1EDF69D-1387-4168-B2BA-4601CF09749AQ30318078-13034729-4E3E-4A2C-AD00-8306DD631A76Q33749281-C4E865DC-584E-4FE4-81AA-09BDE2EB6943Q34031430-B11DD3D6-1AAB-4EA3-A43F-0DCBEDF9F2D7Q34103477-BA7F70B9-4D28-4E50-951E-54344F17383DQ34241357-EFB12403-741E-4A90-BF30-689B5FE5DFC6Q34406428-78525E7C-EADD-475E-BA7D-0294E40B2953Q34785990-C8CDE60C-CB86-4A8D-8436-99F1068C5D49Q34786583-6CB14ECC-DA92-484D-BD05-F8F5D7F865EFQ34796627-235BF4A5-58EF-4FD9-A6A0-AC05C108D473Q34846428-8802C944-E6C7-4FF3-9C0A-71DF452FE0DFQ35030559-A1181F13-C671-42CF-9E64-363098D10F6EQ35043483-4F8EDEEE-C92D-42E7-A5DF-0E3F64A81C36Q35071374-0C517031-F4B6-4EF3-AFD8-684625D092FEQ35503190-D78B2295-7E08-4DED-B0E6-DD32FA2C7A1EQ35530569-6B3032A0-25DE-49E9-A370-AAF987EABC7EQ35606449-E911BE5B-111F-4860-8958-BC40C2824885Q35684721-D5DC39C5-9006-419F-AB02-21E43BA31ADBQ35901218-E837897F-0B1B-4777-9983-4EFBC3E52B03Q35904420-A41351B5-14F0-439A-9E72-DA735B379D41Q35985791-938F2A74-BF18-4CF3-B5E4-FEB943F9100AQ36065449-A121EE1B-B554-4616-87E0-09F5B8F27FEBQ36192734-E662745B-2AF8-4010-981A-51B8716A6264Q36417926-2770AEF8-86FD-45CC-A469-672F2A4D548CQ36746081-B3DB27B8-498D-4B02-A3B4-5EF1B928F0E0Q37127197-F31B1A89-68F8-4747-A38C-39B2C74726EEQ37279106-3C142FB7-4F85-422C-9688-1111D4075354Q37378435-7A37B303-80E3-462F-A284-DCB76B8A5711Q37576183-8D014C39-62A7-41E8-8BFF-3C6241D30ACCQ37672982-F7FF17E6-EF28-4055-A8EC-14FF8F5D1A65Q37836583-4914CF18-435E-4DD5-99B1-60F09F7E755FQ37842757-6C0E39CC-6EA3-4283-A9A8-76B341C55894Q37855988-574E914E-77E3-42C1-AC35-69F2D7C95414Q37947677-27B75EDD-B7C0-46DA-93F7-05D794A47FE5Q37954338-EDFC64A9-2947-4978-BC6A-3CCBAB70F543Q37957420-FC00FAE4-0390-4FA3-B7FB-023E82D18776
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 February 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A bench to bedside view of uremic toxins.
@en
A bench to bedside view of uremic toxins.
@nl
type
label
A bench to bedside view of uremic toxins.
@en
A bench to bedside view of uremic toxins.
@nl
prefLabel
A bench to bedside view of uremic toxins.
@en
A bench to bedside view of uremic toxins.
@nl
P2093
P356
P1476
A bench to bedside view of uremic toxins.
@en
P2093
European Uremic Toxin Work Group
Gerald Cohen
Griet Glorieux
Joachim Jankowski
Philippe Brunet
Ulrich Baurmeister
P304
P356
10.1681/ASN.2007121377
P577
2008-02-20T00:00:00Z